-
Document de presse | 2004.03.17
World Tuberculosis Day (March 24): The Institut Pasteur engaged in the fight
With a third of the world's population infected, 2 million deaths and 8.5 million new cases each year, tuberculosis (TB) is the number two infectious disease in the world after AIDS, without sparing France, where 6300 new cases occurred last year. The prevalence of the resistance to antibiotics and the emergence of multiresistance are worrying at the international level, and is a risk for...
-
Document de presse | 2013.11.27
Clinical trial launched to treat Sanfilippo B syndrome using gene therapy
A phase I/II gene therapy clinical trial for children suffering from Sanfilippo B syndrome, a rare genetic disease, enrolled a first patient in October of this year. The trial is being carried out and coordinated by the Institut Pasteur (the trial’s sponsor), Inserm, AFM-Téléthon and Vaincre les Maladies Lysosomales (VML). It is being conducted at Bicêtre Hospital (AP-HP) in Paris. If the...
-
Document de presse | 2016.11.08
The ADITEC Project on Advanced Immunization Technologies: an European Success Story
30 million Euros of funding, 42 public and private institutions have joined forces for next generation vaccines.The ADITEC project was presented today at the European Parliament as a Success Story.Development of novel immunisation technologies, adjuvants, vectors and delivery systems, formulations and vaccination methods optimised for different age groups, 207 scientific publications, and...
-
News | 2016.10.10
How investigating the population biology of Listeria is ushering in a new era in listeriosis surveillance
By investigating the genome sequence of an international collection of strains of Listeria monocytogenes bacteria, two Institut Pasteur scientists, Sylvain Brisse and Marc Lecuit, have helped improve our understanding of how different Listeria strains circulate across the world. Their method of typing strains using high-throughput sequencing signals a new era for the global monitoring of...
-
Document de presse | 2017.02.23
Why does bronchiolitis only affect infants?
In a study published in the prestigious Immunity journal on February 21, 2017, researchers from the Institut Pasteur in Paris and in Shanghai, Bicêtre Hospital (AP-HP), Paris-Sud University and the CNRS (French National Center for Scientific Research) reported on the discovery of a new group of B lymphocytes, which are only present in infants and are the preferential target of the virus...
-
News | 2017.12.18
Five young researchers from the Institut Pasteur International Network attended the 2017 PhD students' ceremony
Like every year since 2013, the Institut Pasteur organized on December 11th a ceremony in honor of the young graduates who defended their PhD thesis during the 2016-2017 academic year. The 2017 edition honored 34 young Pasteurian scientists, 5 of whom completed their thesis in an institution member of the Institut Pasteur International Network."We are pleased and proud to welcome these young...
-
News | 2018.01.23
Neurobiologist Jean-Pierre Changeux tells us the story of the nicotinic acetylcholine receptor
As the Institut Pasteur prepares to celebrate its 130th anniversary on November 14, 2018, we talk to Jean-Pierre Changeux about the discovery of this ion channel-linked neuroreceptor that revolutionized neuroscience. On February, the researcher publishes a paper in Trends in Neuroscience providing an account of how this receptor's ion channel was structurally identified.The nicotinic...
-
News | 2018.10.04
Multicentric research has identify Leptospira bacteria circulating in Uruguay
In a pioneering work, a multidisciplinary team of researchers from “Miguel C. Rubino” Lab at the Ministry of Livestock (MGAP), the National Agricultural Research Institute (INIA), the state university (Udelar) the Institut Pasteur in Montevideo and the Institut Pasteur (Paris) have identified for the first time the pathogenic strains of the Leptospira bacteria that circulate in Uruguay infecting...
-
Document de presse | 2019.09.30
13th edition of Pasteurdon: combating infectious diseases and cancer
Pasteurdon, a major event that celebrates French research, is focusing on two central themes for its 2019 edition: antimicrobial resistance and cancer. These two fields illustrate the commitment and expertise of the Institut Pasteur's research teams. With the support of patron Alexandra Lamy and more than 40 media partners, the 13th edition of Pasteurdon will take place from October 9 to 13, 2019...
-
News | 2019.11.07
Parkinson's: new discoveries about nanotubes, transporters of toxic proteins
We now know that neurodegenerative diseases are caused by the aggregation of "misfolded" proteins in the brain. These proteins, which are toxic for neurons, spread from cell to cell through tiny tunnels, known as nanotubes. After imaging their structure in detail, (1) scientists in the Institut Pasteur's Membrane Traffic and Pathogenesis Unit, directed by Chiara Zurzolo, are now investigating the...